Human leucocyte interferon-α therapy can induce a second response in treatment of thrombocytosis in patients with neutralising antibodies to recombinant interferon-α2a

Autor:	K. Engman, Christer Paul, E. Törnebohm-Roche, Mats Merup
Rok vydání:	1994
Předmět:	Cancer Research medicine.medical_specialty biology Recombinant interferon Thrombocytosis Group study business.industry Cancer medicine.disease Gastroenterology Regimen Oncology Internal medicine Interferon α Immunology medicine biology.protein In patient Antibody business
Zdroj:	European Journal of Cancer. 30:1729-1730
ISSN:	0959-8049
DOI:	10.1016/0959-8049(94)90604-1
Popis:	6. Morales A. Eidineer D. Bruce AW. Intracavitarv bacillus Calmette Guerin in treatmeit of superficial bladder Turn0rs.J Ural 1976,116, M-184. Herr HO, Laudone VP, Bad.alement BA, et al. BCG therapy alters the progression of superficial bladder cancer. 3 Chir Oncol 1988, 6, 1450-1454. Herr HO, Laudone VP. Intravesical therapy of superficial bladder cancer. Cancer 1988,2,1-5. Pagan0 F, Bassi 0, Milani C, Meneghini A, Maruzzi D, Carbegho A. A low dose BCG regimen IUI superficial bladder cancer therapy: is it effective?_7 Ural 1991,146,32-35. Akaza H, Kamayama S, Coiso K, Aso Y. Ablative and prophylactic effects of BCG Tokyo 172 strain for intravesical treatment in patients with superficial bladder cancer. J Ural 1991,145,427 A. Mori K, Lamm DL, Crawford ED. A trial of BCG versus adriamycin in superficial bladder cancer: a South West Oncology Group Study. Ural Int 1986,41,254-259.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::326f71afad3990a81e3adbd50c28bfb7 https://doi.org/10.1016/0959-8049(94)90604-1 Zobrazit plný text záznamu